The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

The global digital pathology market size was US$ 735.7 million in 2020. The global digital Pathology market size is estimated to reach US$ 1,790.2 million by 2030, growing at a compound annual growth ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® ...

Friday, December 6, 2024. News & Perspective ...

Each tissue microarray is constructed from paraffin-embedded (FFPE) tissue blocks from a specific number of donor cases. Additionally, the microarrays come in various configurations, with a range of ...

We work with researchers to map the distribution of cells in tissues. We use Akoya’s PhenoCycler-Fusion platform to provide high-plex, spatial proteomics images using 40+ markers on a single, 4-micron ...

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies. These high-quality tissue microarrays (TMAs) ...

Tissue microarrays combines tens to hundreds of paraffin-embedded tissue cores into a single paraffin block. It is a practical and highly effective technique for high-throughput analyses of various ...